ºñ¼Ò¼¼Æ÷ Æó¾ÏÁ¾ÀÇ »óÇǼºÀåÀÎÀÚ ¼ö¿ëü »óÅÂ¿Í ÀÓ»ó-º´¸®ÇÐÀû ¿¬°ü¼º: ´Ü¹é ¹ßÇö, À¯ÀüÀÚ ÁõÆø ¹× »ýÁ¸ºÐ¼®
Clinicopathologic Analysis of Epidermal Growth Factor Receptor Status in Non-small Cell Lung Cancer: Protein Expression, Gene Amplification and Survival Analysis
À̽±¸, ÃÖÁø, Àå¼¼Áø,
¼Ò¼Ó »ó¼¼Á¤º¸
À̽±¸ ( Lee Sung-Koo )
°¿ø´ëÇб³ º´¸®°ú
ÃÖÁø ( Choi Jene )
¿ï»ê´ëÇб³ ÀÇ°ú´ëÇÐ ¼¿ï¾Æ»êº´¿ø º´¸®°ú
Àå¼¼Áø ( Jang Se-Jin )
¿ï»ê´ëÇб³ ÀÇ°ú´ëÇÐ º´¸®Çб³½Ç
KMID : 0357920070410060387
Abstract
Background : Abnormal over-expression or gene amplification of epidermal growth factor receptor (EGFR) is important in the prognosis of non-small cell lung cancer (NSCLC). We investigated the frequency of EGFR protein expression and gene amplification, and the correlation between EGFR status and survival in NSCLC.
Methods : We examined 360 cases of microarrayed NSCLC tissues for the EGFR protein expression and EGFR gene amplification using immunohistochemistry and fluorescent in situ hybridization.
Results : EGFR protein expression and EGFR gene amplification occurred in 110 cases (30.6%) and 24 cases
(6.7%), respectively. EGFR prote in expression and gene amplification were more frequent in squamous cell carcinoma than in adenocarcinoma. Differences in EGFR protein expression did not dramatically affect survival curves (p=0.740), but differences in gene amplification did (p<0.05): EGFR gene amplification was associated with a lower 5-year survival rate.
Conclusion : EGFR protein expression and gene amplification showed moderate correlation with each other. EGFR gene amplification predicted a poor prognosis, whereas EGFR protein expression did not.
Å°¿öµå
Carcinoma;Non-small-cell lung;Receptor;Epidermal growth factor;In situ hybridization
¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸
µîÀçÀú³Î Á¤º¸